2022
|
Invention
|
Inhibitors of transglutaminases.
The invention relates to the compound of general formula (I) as... |
|
Invention
|
Inhibitors of transglutaminases. The invention relates to the compound of general formula (l) as ... |
2021
|
Invention
|
Inhibitors of transglutaminases. The invention relates to the compound of general formula (I) as ... |
|
G/S
|
Chemical and biochemical products for industrial use or Chemicals and biochemicals used in scienc... |
|
G/S
|
Enzymes for scientific purposes; enzymes for commercial purposes, namely, for the food industry a... |
|
Invention
|
Systemic formulation of a pyridinone derivate for tg2-related diseases.
The present invention re... |
|
Invention
|
Systemic formulation of a pyridinone derivate for tg2-related diseases. The present invention rel... |
2019
|
Invention
|
Inhibitors of blood coagulation factor xiii. The invention relates to a compound of general formu... |
2013
|
Invention
|
Crystal structure of blood coagulation factor xiiia.
The present invention relates to crystal fo... |
|
Invention
|
Crystal structure of blood coagulation factor xiiia. The present invention relates to crystal for... |
|
Invention
|
Derivatives of pyridinone as inhibitors for tissue transglutaminase. The invention relates to pyr... |
|
Invention
|
Pyridinone derivatives as tissue transglutaminase inhibitors. The invention relates to pyridinone... |
2011
|
Invention
|
Etacrynic acid for use in the treatment of food sensitivity disorders. The invention relates to t... |
2010
|
Invention
|
Stabilized open form transglutaminase as a diagnostic indictor for autoimmune diseases. The prese... |
|
Invention
|
Stabilized open form transglutaminase as a diagnostic indicator for autoimmune diseases. The pres... |
2009
|
G/S
|
Chemical and biochemical products, namely, chemicals, chemical preparations, biochemical preparat... |
|
G/S
|
Chemicals and biochemicals used in industry and science. Medicines, pharmaceutical, veterinary an... |
2008
|
Invention
|
Transglutaminase 6 as a diagnostic indicator of autoimmune diseases.
The embodiments relate to t... |
|
Invention
|
Transglutaminase 6 as a diagnostic indicator of autoimmune diseases. The present invention relate... |
2007
|
G/S
|
Chemical and biochemical products, namely, chemicals, chemical preparations, and biochemical prep... |
|
G/S
|
Chemicals and biochemicals used in industry and science. Dietetic substances for veterinary purpo... |
|
Invention
|
Michael systems as transglutaminase inhibitors. Described herein are peptide derivatives and pept... |
|
Invention
|
Michael systems as transglutaminase inhibitors. The invention relates to peptide derivatives and ... |
2003
|
Invention
|
Transglutaminase gene products. The invention provides a nucleotide sequence comprising at least ... |